what to stack with tirzepatide 5 Best Peptides for Weight Loss NAD+ Tirzepatide Stack: Biomarkers &

Read Unlocking Long-Term Patient Retention: How Sofwave Bridges the Gap for the GLP-1 Generation to learn about non-invasive ultrasound solutions for wrinkle reduction.

FLOW trial findings show semaglutide is associated with sustained improvements in quality of life in chronic kidney disease (CKD).

Promotes appetite reduction and improved fullness response*

What stood out: CagriSema achieved 23.0% weight loss at 84 weeks (efficacy estimand) Tirzepatide achieved 25.5% On the treatment-regimen estimand, weight loss was 20.2% vs 23.6% Primary endpoint not met: CagriSema did not demonstrate non-inferiority vs tirzepatide on weight loss at 84 weeks Why this matters This is a reminder that in obesity pharmacotherapy, very effective and best-in-class are not the same conversation

In a prespecified analysis of the SELECT trial, semaglutide demonstrated significant reductions in cardiovascular mortality and HF hospitalizations for patients with HF and ASCVD

Clinical trials show cumulative weight reduction of 1522% over 68 weeks at higher doses